Management of Unilateral Pleural Effusion

Initial Diagnostic Classification

The protein level of 3 g/dL places this in the borderline range between transudate and exudate, and according to the British Thoracic Society, Light's criteria should be applied using both pleural fluid and serum protein and LDH to accurately differentiate 1, 2.
The American Thoracic Society recommends using ADA primarily as an exclusion test rather than a diagnostic test, with a cutoff of 41.5 U/L providing 97.1% sensitivity, in the context of a patient with a unilateral pleural effusion and ADA level of 39 U/L 3.

In high TB prevalence populations, ADA >40 U/L has 91% sensitivity and 88% specificity for tuberculous pleural effusion, as stated by the American Thoracic Society, but values between 35-45 U/L represent a diagnostic gray zone 4.
The American Thoracic Society also notes that ADA can be elevated in empyema, parapneumonic effusions, rheumatoid pleurisy, malignant lymphoma, IgG4-related disease, and some malignancies, which should be considered in the differential diagnosis of a patient with a unilateral pleural effusion and elevated ADA 3, 4.
ADA may be falsely low in HIV-positive patients with tuberculosis, creating dangerous false negatives, and therefore, the Centers for Disease Control and Prevention recommend considering this possibility in the diagnostic workup of such patients 4.

The British Thoracic Society recommends sending pleural fluid for cytology, LDH, pH, Gram stain, AAFB stain and culture, and placing fluid in blood culture bottles to increase microbiological yield in patients with unilateral pleural effusion 1, 2.
The American Thoracic Society suggests performing CT with the fluid still present to better visualize pleural abnormalities and identify optimal biopsy sites in patients with unilateral pleural effusion 1, 2.

The American College of Radiology recommends looking for pleural thickening, nodularity, mediastinal lymphadenopathy, or underlying parenchymal disease that would guide differential diagnosis in patients with unilateral pleural effusion 5.

The British Thoracic Society recommends that tissue sampling for histology and mycobacterial culture is mandatory, and this is the preferred diagnostic method even when ADA is elevated, in patients with unilateral pleural effusion 3, 4.
The American Thoracic Society notes that pleural biopsy (closed, CT-guided, or thoracoscopic) sent for both histological examination and TB culture achieves approximately 90% diagnostic yield in patients with unilateral pleural effusion 3.

The Centers for Disease Control and Prevention recommend considering empirical anti-tubercular treatment in high TB prevalence areas with compatible clinical context (fever, night sweats, weight loss, known TB exposure) while awaiting culture results in patients with lymphocytic exudate and ADA 39 U/L 3.
The American Thoracic Society suggests proceeding directly to pleural biopsy before initiating treatment in low TB prevalence areas with lymphocytic exudate and ADA 39 U/L 3.

The American Thoracic Society recommends measuring pleural fluid amylase ≥75 U/L combined with ADA/TP ratio <14, which strongly suggests malignant pleural effusion (particularly adenocarcinoma) rather than tuberculosis in patients with unilateral pleural effusion 5.
The American College of Chest Physicians notes that interferon-gamma measurement in pleural fluid has even higher sensitivity (95%) and specificity (96%) than ADA for tuberculous pleurisy and can complement ADA testing in patients with unilateral pleural effusion 4.

The American Thoracic Society warns against relying on ADA alone, as approximately 60% of high-ADA effusions are NOT tuberculous in some series, and recommends considering other diagnostic tests and clinical context in patients with unilateral pleural effusion 3, 4.
The British Thoracic Society advises against assuming low protein (3 g/dL) means transudate, as some exudates have borderline protein levels, and Light's criteria must be applied in patients with unilateral pleural effusion 1, 2.
The American College of Chest Physicians recommends considering cytology alone diagnoses only 60% of malignant effusions, and negative cytology does not exclude malignancy in patients with unilateral pleural effusion 1, 2.

The American Thoracic Society recommends referring to a chest physician immediately if initial pleural fluid analysis does not provide a diagnosis in patients with unilateral pleural effusion 1, 2.
The British Thoracic Society suggests that all undiagnosed exudative effusions require specialist evaluation for consideration of thoracoscopy or advanced imaging in patients with unilateral pleural effusion 1, 2.